Deal Performance Analytics
PharmaDeals Corp-METRx
PharmaDeals Corp-METRx provides vital company metrics that enable comparison of the top 12 Pharmaceutical Companies deal strategies and activities. Covering overall licensing and M&A activity (short and long term), therapeutic focus, plus deal activity relative to R&D spend, this is a key resource for all executives and analysts within biotechnology, pharmaceutical and the financial services sectors.
